Sign In
Get Clay Free →

Suggestions

    Romain Bonnot

    VP, Global Head Oncology Strategy chez Novartis

    Romain Bonnot is a pharmaceutical industry executive with expertise in oncology strategy. He currently serves as the Market Access and Innovative Value Strategies Director for Oncology at AstraZeneca.2 Previously, Bonnot held the position of Vice President and Global Head of Strategy for Oncology at Novartis.3

    Bonnot is a trained pharmacist with a Doctor of Pharmacy degree.5 He has extensive experience in oncology strategy and has been involved in various aspects of cancer treatment development, including antibody-drug conjugates (ADCs) and CAR-T therapies.13

    Throughout his career, Bonnot has demonstrated a commitment to advancing cancer treatments. He has shared insights on topics such as decentralized manufacturing for CAR-T therapies3 and the potential of ADCs in oncology.15 Bonnot is also active on LinkedIn, where he frequently posts about developments in oncology and pharmaceutical strategy.467

    Highlights

    Mar 22 · zs.com
    [PDF] Decentralized manufacturing: Unlocking CAR-T's potential - ZS
    Mar 12 · zs.com
    Antibody-drug conjugates (ADCs): Oncology's next revolution | ZS
    Aug 4 · pharmaphorum.com
    Antibody drug conjugates – The time is now - pharmaphorum

    Related Questions

    What are Romain Bonnot's key achievements at Novartis?
    How has Romain Bonnot contributed to the development of antibody-drug conjugates?
    What strategies has Romain Bonnot implemented in his role at Novartis?
    How does Romain Bonnot's background as a pharmacist influence his approach to oncology?
    What are the future directions for oncology strategy under Romain Bonnot's leadership?
    Romain Bonnot
    Add to my network

    Location

    Zurich, Switzerland